Treatment (Tx) guidelines for skin and mucosal events in patients with solid tumors (pts) receiving TH‐302, a tumor selective, hypoxia‐activated prodrug.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. J. Borad, N. Boyer, J. G. Curd, U. K. Sunkara, K. Awerkamp, M. E. Lacouture
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2248291032